Skip to main content
. 2009 Apr;19(2):119–126. doi: 10.1089/cap.2008.040

Table 3.

Fluvoxamine dose at Time of First Activation and Dose at Week 8 among the 10 Subjects Who Developed Activationa

Subject Week Dose at time of first activation End of study week Dose at the end of the study (mg)
 1 4 50 8 75
 3 6 150 8 100
 4 8 200 8 200
 5 7 200 8 150
 6 4 125 8 100
 7 1 75 8 100
 9 2 75 8 75
10 4 125 8 125
a

Two individuals (subjects 2 and 8) were omitted because they terminated the study before week 8.